Ubs Asset Management Americas Inc Organogenesis Holdings Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.89 - $2.93 $34,103 - $52,868
18,044 Added 22.38%
98,659 $210,000
Q2 2022

Aug 12, 2022
BUY
$4.74 - $8.15 $203,227 - $349,431
42,875 Added 113.61%
80,615 $393,000
Q2 2021

Aug 16, 2021
BUY
$14.92 - $23.23 $563,080 - $876,700
37,740 New
37,740 $627,000

Others Institutions Holding ORGO

# of Institutions
118
Shares Held
64.3M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $437M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email